Effects of skin washing on systemic absorption of testosterone in hypogonadal males after administration of 1.62% testosterone gel

Curr Med Res Opin. 2012 Feb;28(2):271-9. doi: 10.1185/03007995.2011.652256. Epub 2012 Jan 17.

Abstract

Objective: The impact of washing on the pharmacokinetics, systemic absorption and residual testosterone on the skin after application of a 1.62% testosterone gel was investigated in an open-label, randomized, three-way crossover study in hypogonadal men.

Research design and methods: Twenty-four hypogonadal men (total testosterone <300 ng/dL) applied 5 g of 1.62% gel (81 mg testosterone) once daily to the shoulders/upper arms for 7 days during each of three consecutive treatment periods. On the 7th dosing day of each period, the skin was washed (soap/water) at one of the following times: 2, 6, or 10 hours post-dose. Pharmacokinetic serum samples were collected at baseline, and on days 6 (no washing) and 7 (with washing) of each treatment period. Skin stripping for determination of residual testosterone was also performed on days 6 and 7. A single location on the application site was stripped a total of 10 times. Testosterone was extracted from the tape strips using ethanol, and concentrations were determined using high performance liquid chromatography with diode array detection (HPLC-UV).

Main outcome measures: Testosterone C(max), AUC(0-24), average concentration over the dosing interval (C(av)), and safety were assessed.

Results: Washing at 2 and 6 hours caused a 10-14% decrease in AUC(0-24) and C(av), but not C(max). Washing 10 hours after gel application had no effect on C(max), AUC(0-24), or C(av). Skin washing decreased the mean amount of testosterone remaining on the skin surface by at least 81%.

Conclusions: Washing the site of gel application as soon as 2 hours after application had little impact on bioavailability and was effective in reducing residual testosterone on the skin. This finding may be important to prevent secondary transfer.

Study limitations: The experimental conditions using uniform timing and procedures for dose administration and washing may not fully reflect real world circumstances. CLINICAL TRIAL REGISTRATION NCT NUMBERS: Study was not registered (first subject enrolled 22 December 2006).

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Administration, Cutaneous
  • Adult
  • Aged
  • Baths*
  • Cross-Over Studies
  • Gels / administration & dosage
  • Gels / therapeutic use
  • Hormone Replacement Therapy / methods*
  • Humans
  • Hypogonadism / drug therapy
  • Male
  • Middle Aged
  • Skin / drug effects
  • Skin Absorption*
  • Testosterone / administration & dosage
  • Testosterone / adverse effects*
  • Testosterone / blood
  • Testosterone / pharmacokinetics*

Substances

  • Gels
  • Testosterone